NCT00224523View on ClinicalTrials.gov

Long Term Safety Of GW685698X Via Nasal Biopsy

PHASE3CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

GW685698X

DRUG

mometasone furoate

Trial Locations (4)

3000

GSK Investigational Site, Leuven

1105 AZ

GSK Investigational Site, Amsterdam

6525 EX

GSK Investigational Site, Nijmegen

2566 MJ

GSK Investigational Site, The Hague

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY